Cleared Traditional

OsseOne Dental Implant System (K233271) - FDA 510(k) Clearance

Class II Dental device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K233271 · Synoross Dba Osseone · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2025
Decision
587d
Days
Class 2
Risk

K233271 is an FDA 510(k) clearance for the OsseOne Dental Implant System. Classified as Implant, Endosseous, Root-form (product code DZE), Class II - Special Controls.

Submitted by Synoross Dba Osseone (Glendale, US). The FDA issued a Cleared decision on May 8, 2025 after a review of 587 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3640 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Dental submissions.

View all Synoross Dba Osseone devices

Submission Details

510(k) Number K233271 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 2023
Decision Date May 08, 2025
Days to Decision 587 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
460d slower than avg
Panel avg: 127d · This submission: 587d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DZE Implant, Endosseous, Root-form
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.

Regulatory Consultant

Blackwell Device Consulting
Angela Blackwell

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DZE Implant, Endosseous, Root-form

All 304
Devices cleared under the same product code (DZE) and FDA review panel - the closest regulatory comparables to K233271.
Bioline Dental Implant System
K250872 · Bioline Dental Implant Systems, Ltd. · Jun 2025
MBA Biotech Implant System
K243002 · MBA Biotech Co., Ltd. · Jun 2025
CeraRoot TL Implant System (TL)
K242072 · Ceraroot SL · May 2025
DAND Dental Implant System
K250176 · D.A.N.D. Metal Industries North, Ltd. · Apr 2025
SD Implant System
K241703 · Arum Dentistry Co., Ltd. · Feb 2025
LONGY Implant and LONGY-N Implant
K241462 · Noris Medical , Ltd. · Feb 2025